0
0.5
1
1.5
2+
Mortality
85%
Improvement
Relative Risk
Favipiravir for COVID-19 Yulia et al. LATE TREATMENT
Is late treatment with favipiravir beneficial for COVID-19?
Retrospective 432 patients in Indonesia (July - December 2020)
Lower mortality with favipiravir (not stat. sig., p=0.052)
c19early.org
Yulia et al., Pathophysiology, March 2022
Favors favipiravir
Favors control